Skip to Main Content

Paper Details

KEYNOTE-042 and the role for single agent pembrolizumab in patients with PD-L1 tumor proportion score 1-49.
J Thorac Dis
5
2019
Author NameAffiliation
Daniel MorgenszternWashington University School of Medicine
  • 1 - 1

Datasets

Release 1.2